Improved 3D-QSAR CoMFA of the dopamine transporter blockers with multiple conformations using the genetic algorithm

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Dopamine transporter (DAT) is a key target for treating cocaine addiction and neurological disorders.
• Developing effective DAT blockers requires understanding ligand-protein interactions.
• 3D-QSAR/CoMFA approaches are valuable for structure-activity relationship studies.

Purpose of the Study:

• To build and refine 3D-QSAR/CoMFA models for piperidine-based DAT blockers.
• To explore the impact of ligand conformational flexibility on DAT binding.
• To guide the rational design of novel DAT inhibitors.

Main Methods:

• Utilized the Genetic Algorithm Similarity Program (GASP) to generate a pharmacophore model.
• Employed the Flexible Superposition (FlexS) technique for multiple ligand conformations.
• Applied Genetic Algorithms to optimize conformation selection for CoMFA modeling.

Main Results:

• Developed detailed CoMFA models by incorporating multiple ligand conformations.
• Observed that ligand flexibility, particularly 3alpha-substituents, influences binding site interactions.
• Models demonstrated comparability, with variations attributed to conformational adaptability.

Conclusions:

• Flexible conformational analysis enhances the detail of 3D-QSAR/CoMFA models for DAT blockers.
• Findings offer insights for designing improved DAT inhibitors.
• This research supports the development of therapeutics for cocaine addiction and neurological conditions.